Evaluation of sialic acid levels in patients with hydatidiform mole: a preliminary study
AuthorÖzcan, Hüseyin Çağlayan
Uğur, Mete Gürol
MetadataShow full item record
CitationÖzcan, H. Ç., Öztürk, E., Sucu, S., Uğur, M. G., Kutlar, İ., Balat, Ö. ve Erbağcı, B. (2016). Evaluation of sialic acid levels in patients with hydatidiform mole: a preliminary study. Clinical and Experimental Obstetrics & Gynecology, 43(3), 414-416. https://dx.doi.org/10.12891/ceog2156.2016
Purpose of investigation: This study aims to investigate whether hydatidiform mole (HM) disease with malignant potential is significantly associated with increased sialic acid (SA) levels. Materials and Methods: A total of 114 women were enrolled in this study. Patients were divided into three groups including HM (Group 1, n=34), control group including non-pregnant healthy patients (Group 2, n=42), and another control group including healthy pregnant patients within 12 weeks of gestation (Group 3, n=38). Serum-free SA levels were measured. Results: There was a statistically significant difference in serum-free SA levels among the groups (p < 0.001). Patients with HM had significantly higher levels compared to the control groups. Conclusion: The present study results showed that there was a significant correlation between HM and serum SA level.